Investor Relations

Directors' Profile

DATO’ SERI ABDUL RAZAK JAAFAR
Independent Non-Executive Chairman

Male, Age 61, Malaysian

Appointed on
1 October 2024

Last re-election on
None

Working Experience and Occupations
Dato’ Seri Abdul Razak’s distinguished career in public service began in 1988 as a Public Relations Officer at the Seremban City Council. He joined the Administrative and Diplomatic Cadet (PTO) in 1991, marking the start of his impactful journey in Government.

From 1992 to 1996, he played a key role in national security as Assistant Director at the Federal Special Task Force in Sabah and the National Security Council under the Prime Minister’s Office. His contributions were instrumental in shaping national security strategies during a pivotal time.

In 1996, Dato’ Seri Abdul Razak transitioned to the Selangor State Government, where he held several leadership positions, including Head of Internal Audit & Public Complaints and Assistant Secretary for Services & Training. His tenure marked a significant contribution to state governance and public service delivery.

Rising through the ranks, he was appointed Director of Community Development at Petaling Jaya Municipal Council in 2002, followed by Director of Corporate Planning at Ampang Jaya Municipal Council in 2003. His leadership was further recognised in 2006 when he became Deputy President of the Sepang Municipal Council, and later, President of the Kuala Langat Municipal Council in 2009, where he led transformative municipal projects.

In 2012, Dato’ Seri Abdul Razak moved to the Prime Minister’s Office (UKAS, PMO), where he held multiple strategic roles, including Director for Security, Housing, and Land Development, and played a key role in public-private partnerships. His expertise in policy, public administration, and inter-governmental coordination was invaluable.

In 2013, his career reached new heights when he was appointed Division Secretary at the Ministry of Defence (MINDEF), overseeing Finance and Procurement divisions, where his leadership enhanced financial operations and procurement strategies.

From 2015 to 2019, as Deputy Secretary General at the Ministry of Works, he shaped national infrastructure policies and strategic development. In 2019, he was appointed State Secretary for Penang, driving the state’s development agenda and improving governance efficiency.

Most recently, Dato’ Seri Abdul Razak served as Secretary General at the Ministry of Higher Education from 2021 to 2023, where he provided visionary leadership in shaping Malaysia’s higher education policies and initiatives. Throughout his illustrious career, Dato’ Seri Abdul Razak has been a driving force in public administration, governance, and national development.

Qualification(s)
• Master of Science in Human Resource Development, Universiti Putra Malaysia
• Postgraduate Diploma in Public Management, National Institute of Public Administration (INTAN)
• Bachelor of Communication with Honours, Universiti Kebangsaan Malaysia

Board Skills and Experience Matrix
Human Resource
Public Administration

Board Committee(s)
None

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year
4/4

Male, Age 52, Malaysian

Appointed on 1 March 2024
Redesignated as Managing Director on 1 September 2024

Last re-election on
5 June 2024

Working Experience and Occupations
Dato' Zulkifli’s career began as a legal counsel at Panglima Aces Sdn. Bhd. in 1997. Rapidly ascending the ranks, he distinguished himself as an advocate and solicitor at Messrs Raslan Loong within the same year and by 2002, Dato' Zulkifli became a partner at Messrs Rashid Zulkifli. Beyond his legal practice, Dato' Zulkifli serves as a director and major shareholder of MMA Resources Sdn. Bhd., an oil & gas company.

In addition to his corporate responsibilities, Dato' Zulkifli is actively engaged in shaping the landscape of development and governance. Currently, he holds the positions of Chairman and Director at Era Universe Development Sdn. Bhd., a development company.

Dato' Zulkifli had served as the Legal Advisor for Johor State Government Linked Companies (GLC). His diverse portfolio included directorships in esteemed organisations such as the Cooperative Commission of Malaysia, the regulator body of cooperatives in the country; Board of Trustee of the Foundation of Research and Transformation, an independent think tank research body of the Prime Minister’s Office; and Songa Offshore Malaysia Sdn. Bhd.

Internationally, Dato' Zulkifli was a director and management member of the Chartridge Conference Centre (UK) Limited, overseeing the operations of four hotels and conference centres in the United Kingdom.

In 2021, Dato' Zulkifli assumed the position of Chairman at ldaman Pharma Manufacturing Sdn. Bhd., a subsidiary of Pharmaniaga Berhad (Pharmaniaga) and subsequently, appointed as the Executive Director of Pharmaniaga in March 2022. In February 2023, he was redesignated as Deputy Chief Executive Officer of Pharmaniaga.

In January 2023, Dato' Zulkifli was appointed as a board member of University Sains Islam Malaysia (USIM) and in June 2023, he was appointed to be the Chairman of USIM Tijarah Holdings Sdn. Bhd., the holding company of USIM. He was also appointed as the Chairman of the Advisory Panel (Faculty of Sharia and Law) and the Investment Committee.

On 1 March 2024, Dato' Zulkifli was appointed as the Executive Director of Pharmaniaga, taking over the role and functions of the Executive Committee which was subsequently dissolved.

Qualification(s)
• Admission to Malaysian Bar in 1996
• Advocate and Solicitor of the High Court of Malaya
• Certified Patent Agent
• Bachelor of Laws (Honours), Universiti Islam Antarabangsa Malaysia

Board Skills and Experience Matrix
Legal & Regulatory
Corporate Planning & Development

Board Committee(s)
None

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year
11/11

Male, Age 53, Malaysian

Appointed on
20 November 2020

Last re-election on
12 June 2023

Working Experience and Occupations
Dr. Abdul Razak is the Founding Director of Bait Al Amanah, a political security and international affairs think tank based in Kuala Lumpur.

He is currently the Special Advisor to the Foreign Minister of Malaysia and Malaysia’s Representative to the Advisory Board of ASEAN Institute for Peace and Reconciliation (ASEAN-IPR), Jakarta. He is also a member of the Board of Directors at Universiti Malaysia Sarawak (UNIMAS) and the Board of Governors of MAHSA University.

Abdul Razak previously served as the member of the Consultative Council on Foreign Policy, Ministry of Foreign Affairs, a senior advisor in the Ministry of Higher Education Malaysia and a consultant to the special consultancy team on globalisation at the National Economic Action Council (NEAC) of the Prime Minister’s Department.

Dr. Abdul Razak was also a faculty member at the National Defence University of Malaysia, teaching international security, international law and global affairs. At present, he is an Adjunct Professor in a few national and international universities.

On the international front, Dr. Abdul Razak had served as consultant and policy advisor in peace building and international development strategies in the Middle East, North Africa, ASEAN and the Southern Pacific region. He was also engaged by the European Union and the World Bank as a subject matter expert on human development and human security-related issues.

He is a qualified legal counsel, having trained in Malaysia and the United Kingdom (UK) and received his PhD in Law and International Security from the University of Leeds, UK. He did his fellowship at East West Centre (University of Hawaii) and was a visiting researcher at Colombia University. He also attended leadership executive programmes at Sad Business School (Oxford University) and Kennedy School of Government (Harvard University).

On 22 February 2023, Dr. Abdul Razak was redesignated as Senior Independent Non-Executive Director of Pharmaniaga.

Qualification(s)
• Doctor of Philosophy in Law (International Security), University of Leeds, United Kingdom
• Master of Laws in International Trade Law, University of Kent at Canterbury, United Kingdom
• Bachelor of Laws (Honours), Universiti Islam Antarabangsa Malaysia

Board Skills and Experience Matrix
Human Resource
Legal & Regulatory

Board Committee(s)
• Chairman of Nominating and Remuneration Committee
• Chairman of Sustainability Committee
• Member of Audit Committee
• Member of Board Risk and Investment Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year
16/17

Male, Age 47, Malaysian

Appointed on
10 August 2023

Last re-election on
5 June 2024

Working Experience and Occupations
Ashraf is currently the Chief Executive Officer of Lembaga Tabung Angkatan Tentera (LTAT). He was appointed on 1 April 2024. Prior to his appointment as the Chief Executive Officer in LTAT, he served as the Chief Financial Officer since March 2020. He had also held various senior management positions namely Chief Financial Officer of Ahmad Zaki Resources (2017-2020), Associate Director, Corporate Advisory and Structuring at MIDF Amanah Investment Bank (2015-2016), General Manager, Finance Special Projects at Johawaki Holdings Sdn. Bhd. (2013-2015) and Associate Director of Prokhas Sdn. Bhd. for the Capital Market (2009-2013).

He commenced his career at Ernst and Young (Dublin) as an Audit Senior in 2002. Thereafter, he worked in several companies in Europe namely CUNA Mutual Life Assurance (Europe) Limited (Dublin) as Financial Accountant European Region (2005-2007) and UBS Investment Bank (London) as Regulatory Reporting Analyst (2007-2009).

Qualification(s)
• Chartered Accountant, Malaysian Institute of Accountants
• Member of the Association of1Chartered Certified Accountants
• Bachelor of Accountancy (Honours), Universiti Tenaga Nasional

Board Skills and Experience Matrix Accounting & Finance
Corporate Planning & Development

Board Committee(s)
None

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
• Affin Bank Berhad

Directorship in public companies
• Boustead Holdings Berhad
• Boustead Plantations Berhad

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None Board Meetings attended in the financial year
14/17

Female, Age 50, Malaysian

Appointed on
20 August 2021

Last re-election on
5 June 2024

Working Experience and Occupations
Sarah has over 22 years of experience in corporate finance transactions involving equity issuance, mergers and acquisitions, corporate restructuring and corporate valuation. She began her career in investment banking with Malaysian International Merchant Bankers Berhad in 2001 after obtaining her professional qualifications from PricewaterhouseCoopers.

Later in her career, she joined other banking institutions in Malaysia such as Amlnvestment Bank Berhad, Aseambankers Malaysia Berhad (now known as Maybank Investment Bank Berhad) and RHB Investment Bank Berhad.

Presently, Sarah sits as Executive Director of Reneuco Berhad and is also the Executive Director of 3p Capital Advisers Sdn. Bhd., a company licensed with the Securities Commission Malaysia that provides advisory services to the capital market players.

Qualification(s)
• Certified Practising Accountant, CPA Australia
• Capital Markets Services Representative’s License (CMSRL)
• Bachelor of Commerce (Accounting), University of Canberra

Board Skills and Experience Matrix
Accounting & Finance
Corporate Planning & Development

Board Committee(s)
• Chairman of Audit Committee
• Chairman of Board Tender Committee
• Member of Nominating and Remuneration Committee
• Member of Board Risk and Investment Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
• Reneuco Berhad
• PT Millennium Pharmacon International Tbk

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year
17/17

Male, Age 49, Malaysian

Appointed on
1 March 2024

Last re-election on
5 June 2024

Working Experience and Occupations
Dato’ Mohd Zahir has over 27 years of experience in accounting, finance and asset management. He established his career as an auditor with various accounting firms including PricewaterhouseCoopers and Deloitte & Touche in both of its Malaysia and overseas offices. He was the Chief Financial Officer of Tracoma Holdings Berhad, a company focusing on the manufacturing of automotive components before appointed as the Audit Director for Baker Tilly Monteiro Heng. Dato’ Mohd Zahir subsequently held the position of Head of Operations of Principal Asset Management Berhad (formerly known as CIMB-Principal Asset Management Berhad).

Dato’ Mohd Zahir then joined Prasarana Malaysia Berhad (Prasarana) as the Group Chief Financial Officer and was promoted to Chief Executive Officer of Prasarana Integrated Development (PRIDE), a wholly owned subsidiary of Prasarana. Dato’ Mohd Zahir subsequently became the Managing Director of Zahir Irkaz Advisory PLT and then appointed as Managing Director and Group Chief Executive Officer of Destini Berhad.

Dato’ Mohd Zahir graduated with a Bachelor of Commerce (Accounting) degree from the University of New South Wales, Australia. He attended Oxford Global CEO Programme at Sad Business School, Oxford University, England. He is a Certified Financial Planner, a fellow of the Chartered Accountants Australia & New Zealand and a member of Malaysian Institute of Accountants.

Currently, Dato’ Mohd Zahir is the Independent Non-Executive Director of Universiti Malaya Medical Centre and Universiti Malaya. He also sits as an Independent Non-Executive Director of Mycron Steel Berhad and Olympia Industry Berhad.

Qualification(s)
• Certified Financial Planner
• Fellow, Chartered Accountants Australia & New Zealand
• Bachelor of Commerce (Accounting), University of New South Wales, Australia

Board Skills and Experience Matrix
Accounting & Finance

Board Committee(s)
• Chairman of Board Risk and Investment Committee
• Member of Audit Committee • Member of Board Tender Committee
• Member of Nominating and Remuneration Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
• Mycron Steel Berhad
• Olympia Industries Bhd

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None Board Meetings attended in the financial year
11/11

Female, Age 64, Malaysian

Appointed on
1 March 2024

Last re-election on
5 June 2024

Working Experience and Occupations
Dato’ Dr. Faridah brings to the Board over 37 years of experience in pharmaceutical industry involving pharmacy development, regulatory compliance and drug management.

Dato’ Dr. Faridah started her career with the National Pharmaceutical Control Bureau in 1986 upon graduating with a Bachelor of Pharmacy from the Universiti Sains Malaysia. She has held several important posts in the Government sector, namely at the Ministry of Health, Kuala Lumpur Hospital and the National Pharmaceutical Regulatory Agency. The highest post that she held was Senior Director for Pharmaceutical Services Programme before her retirement. Upon her departure from the Ministry, she was appointed as an Academic Fellow at the School of Pharmaceutical Sciences, Universiti Sains Malaysia from June 2021 to May 2023.

In addition to her degree and Diploma in Medical Microbiology from the Institute for Medical Research, Dato’ Dr. Faridah received her Master of Science degree in Pharmaceutical Services and Medicines Control from the University of Bradford, United Kingdom. She later pursued and received her Doctor of Philosophy (Ph.D.) in Pharmacoeconomics from Universiti Sains Malaysia in 2006.

Qualification(s)
• Doctor of Philosophy in Pharmacoeconomics, Universiti Sains Malaysia
• Master of Science in Pharmaceutical Services and Medicines Control, University of Bradford, United Kingdom
• Diploma in Medical Microbiology, Institute for Medical Research, Malaysia
• Bachelor of Pharmacy (Honours), Universiti Sains Malaysia

Board Skills and Experience Matrix
Legal & Regulatory
Medical & Pharmaceuticals

Board Committee(s)
• Member of Nominating and Remuneration Committee
• Member of Sustainability Committee
• Member of Board Risk and Investment Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year
11/11

Male, Age 60, Indonesian

Appointed on
1 March 2024

Last re-election on
5 June 2024

Working Experience and Occupations
Dr. Imam brings a wealth of experience and expertise to the Board, supported by a strong educational foundation and decades of professional experience in the pharmaceutical industry.

With a broad expertise spanning marketing and sales strategy, business strategy, retail, pharmaceuticals, business development, and healthcare, he brings a multifaceted skill set to the boardroom, ready to drive strategic initiatives and propel organisational success to new heights.

After earning his Bachelor of Pharmacy degree in 1989, Dr. Imam began his career journey in the pharmaceutical field. Driven by a passion for innovation and strategic foresight, he pursued a Master of Strategic Management to equip himself with the knowledge and skills needed to navigate the complexities of the modern business landscape. Along with the development of science and the challenges of the pharmaceutical industry in the future, Dr. Imam has completed his doctoral programme in Pharmaceutical Sciences at Airlangga University in December 2024.

In 2011 to 2019, he was appointed as President Director of PT Kimia Farma Apotek. Furthermore, Dr. Imam was given a new assignment as Director of Business Development at PT Kimia Farma Tbk in 2019 to strengthen PT Kimia Farma Tbk’s position as a holding company to adapt to new challenges and provide invaluable insights in establishing strategic partnerships and driving sustainable growth initiatives.

Recognised for his outstanding contributions, Dr. Imam held the position of Marketing & Commercial Director from 2021 to 2022, further highlighting his expertise in creating robust marketing and sales strategies to capture the ever-evolving market dynamics.

Throughout his illustrious career, Dr. Imam has played a significant role in winning various awards in the pharmaceutical sector in Indonesia, especially in the field of marketing.

Qualification(s)
• Doctor of Pharmaceutical Sciences, Airlangga University, Indonesia
• Master of Strategic Management, PPM School of Management, Indonesia
• Bachelor of Pharmacy, Airlangga University, Indonesia

Board Skills and Experience Matrix
Business & Economics
Medical & Pharmaceuticals

Board Committee(s)
• Member of Nominating and Remuneration Committee
• Member of Audit Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
• PT Millennium Pharmacon International Tbk

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year
11/11

Female, Age 73, Malaysian

Appointed on
19 July 2024

Last re-election on
None

Working Experience and Occupations
Dr. Mary Jane began her career as a Research Assistant on a Welcome Trust Grant at the Dunn School of Pathology, University of Oxford, United Kingdom from 1980 to 1984. She then moved to the Research Institute of the Scripps Clinic in La Jolla, California, United States of America (USA), where she was a Postdoctoral Fellow from January to April 1985.

From 1985 to 1989, Dr. Mary Jane served as a Lecturer at the School of Medical Sciences at Universiti Sains Malaysia, before moving to the School of Pharmaceutical Sciences, where she held the position of Lecturer from 1990 to 1994. She was subsequently appointed Associate Professor at the School of Pharmaceutical Sciences, Universiti Sains Malaysia, from 1994 to 1995.

In 1995, Dr. Mary Jane became the Founding Director of the Institute of Health and Community Medicine at Universiti Sarawak Malaysia (UNIMAS), where she served until 2010, establishing the institute and advancing research in public health and community medicine. From 2009 to 2018, Dr. Mary Jane was the Founder and Chief Scientific Officer at Sentinext Therapeutics Sdn. Bhd., where she played a pivotal role in leading scientific and technological innovations in biotechnology.

Currently, she is the Chief Technical Officer at Integrated Research Associates LLC and the Founder and Director of both MAB Explorations Sdn. Bhd. and Venture Technologies Sdn. Bhd., where she drives cuttingedge research, strategic initiatives, and technological advancements in the field of science and innovation.

Qualification(s)
• Doctor of Philosophy, University of Oxford, United Kingdom
• Master of Arts, Columbia University, New York, USA
• Bachelor of Arts, Princeton University, New Jersey, USA

Board Skills and Experience Matrix
Medical & Pharmaceuticals

Board Committee(s)
• Member of Sustainability Committee
• Member of Board Tender Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year
5/6

Male, Age 64, Malaysian

Appointed on
19 July 2024

Last re-election on
None

Working Experience and Occupations
Dato’ Seri Dr. Hj. Awaludin began his career in the medical field as a Housemanship at Hospital Besar Seremban from 1985 to 1986. He then served as a Medical Officer at Hospital Besar Seremban from 1986 to 1987, before moving to Pusat Kesihatan Besar Padang Lebar, Batu Kikir, Negeri Sembilan as a Health Officer from 1987 to 1991. Following this, he worked as a Medical Officer for Tabung Haji in Mekah, Saudi Arabia from 1989 to 1990. In 1991, he transitioned into private practice, becoming a Private Medical Practitioner at Klinik Kita in Ampang, Selangor, where he practiced until 2004.

In his political career, Dato’ Seri Dr. Hj. Awaludin was elected as the Member of the Negeri Sembilan State Legislative Assembly (Wakil Rakyat) for Kota Rembau, serving from 2004 until June 2023. He also served as the Chairman of the Board of Directors of MAINS Zakat Sdn. Bhd. (Pusat Zakat Negeri Sembilan) from 2014 to 2018. From 2013 to 2018, Dato’ Seri Dr. Hj. Awaludin held the position of Speaker of the Negeri Sembilan State Legislative Assembly, playing a key role in the legislative process and governance at the state level.

Qualification(s)
• Bachelor of Medicine, Bachelor of Surgery (MBBS), Universiti Malaya

Board Skills and Experience Matrix
Medical & Pharmaceuticals

Board Committee(s)
• Member of Audit Committee
• Member of Board Risk and Investment Committee
• Member of Board Tender Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year
6/6

Male, Age 61, Malaysian

Appointed on
1 September 2025

Working Experience and Occupations
Datuk Mohd Adzahar brings with him over 37 years of extensive experience in the banking and financial services sector.

He began his career in London as a Trainee Accountant/Auditor at Sagoo & Co after completing his ACCA Level III at Emile Woolf College in 1988. Returning to Malaysia, he joined Bumiputra Merchant Bankers Berhad from 1988 to 1994, advancing to Corporate Banking Manager with responsibilities in corporate lending, syndicated debts, and treasury functions. He later became Corporate Finance Manager at Malaysian Helicopter Berhad, where he played a key role in financing the acquisition of Malaysia Airlines Berhad and managing corporate investments.

In 1995, he transitioned to PMCare Sdn. Bhd. as Chief Executive Officer and Executive Director, where he was instrumental in developing its core operating system and driving the company's growth in medical management outsourcing. Over the years, he also held board roles in notable companies including Kencana Petroleum Berhad, SapuraKencana Petroleum Berhad, Symphony House Berhad, Edra Global Energy Berhad, and TH Plantations Berhad.

Datuk Mohd Adzahar currently serves as an Independent Non-Executive Director at Cypark Resources Berhad and Glomac Berhad, while also remaining a Director at PMCare Sdn. Bhd. He is also a Fellow of the Association of Chartered Certified Accountants (UK) and a member of the Malaysian Institute of Accountants.

Qualification(s)
• Fellow, Association of Chartered Certified Accountants (UK)
• Member of Malaysian Institute of Accountants (MIA)
• Member of Financial Planning Association of Malaysia

Details of any interest in the securities of Pharmaniaga Berhad
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

Male, Age 38, Malaysian

Appointed on
20 May 2024

Last re-election on
Not Applicable

Working Experience and Occupations
Firdaus began his career as an Engineer, Operations & Maintenance at UEM Edgenta Berhad in June 2009 to December 2010, where he contributed to operational processes and maintenance efficiency. He then advanced to Executive, Corporate Strategy & Business Development in 2011 for a year and later held the role of Senior Executive, Operations Control for the whole year of 2012.

In 2013, he took on the role of Assistant Manager, Managing Director’s Office at UEM Edgenta Berhad, before moving to UEM Sunrise Berhad as Assistant Manager, Corporate Planning from July 2014 to May 2016. During this period, he played a crucial role in corporate strategy, business development and operational improvements.

From June 2016 to October 2021, Firdaus served as Head of Business Development, Group Strategy at Naza Corporation Holdings Sdn. Bhd., leading business development and strategic initiatives that drove growth and operational success. Additionally, he took on the role of Interim Head of Company at Naza Communications Sdn. Bhd. from September 2019 to April 2020, managing operations during a transitional phase.

In his most recent roles, Firdaus was the Senior Manager, Growth & Strategy at Capital A Berhad from November 2021 to February 2023, where he was instrumental in executing growth strategies and driving the company’s expansion. He currently serves as the Head of the Strategic Asset Management Department at Lembaga Tabung Angkatan Tentera (LTAT), where he oversees the reporting, evaluation, restructuring, and management of LTAT’s strategic investee companies. His focus is on improving financial performance, driving growth, and enhancing shareholder value, while ensuring alignment with LTAT’s key objectives and targets.

Qualification(s)
• Master of Management, Universiti Tun Abdul Razak
• Bachelor of Chemical Engineering, Universiti Putra Malaysia

Board Skills and Experience Matrix
Corporate Planning & Development

Board Committee(s)
None

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year
1/1